Characterization of SARS-CoV-2 intrahost genetic evolution in vaccinated and non-vaccinated patients from the Kenyan population
Open Access
- 17 June 2025
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 99 (6) , e0048225
Abstract
Vaccination is a key control measure of coronavirus disease 2019 by preventing severe effects of disease outcomes, reducing hospitalization rates and death, and increasing immunity. However, vaccination can affect the evolution and adaptation of SARS-CoV-2 largely through vaccine-induced immune pressure. Here, we investigated intrahost recombination and single nucleotide variations (iSNVs) on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome in non-vaccinated and vaccinated sequences from the Kenyan population to profile intrahost viral genetic evolution and adaptations driven by vaccine-induced immune pressure. We identified recombination hotspots in the S, N, and ORF1a/b genes and showed the genetic evolution landscape of SARS-CoV-2 by comparing within- and inter-wave recombination events from the beginning of the pandemic (June 2020 to December 2022) in Kenya. We further reveal differential expression of recombinant RNA species between vaccinated and non-vaccinated individuals and perform an in-depth analysis of iSNVs to identify and characterize the functional properties of non-synonymous mutations found in ORF-1 a/b, S, and N genes. Lastly, we detected a minority variant in non-vaccinated patients in Kenya, with an immune escape mutation S255F of the spike gene, and showed differential recombinant RNA species. Overall, this work identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape. IMPORTANCE: The impact of vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic diversity in Kenya and much of Africa remains unknown. This can be attributed to lower sequencing rates; however, this information is relevant to improvement in vaccine and antiviral research. In this study, we investigated how vaccination and SARS-CoV-2 transmission waves affect intrahost non-homologous recombination and single nucleotide variations (iSNVs). We identified unique in vivo mutations and intrahost recombination patterns in SARS-CoV-2, which could have significant implications for virus evolution, virulence, and immune escape. We also demonstrate a methodology for studying genetic changes in a pathogen by a simultaneous analysis of both intrahost single nucleotide variations and recombination events. The study reveals the diversity of SARS-CoV-2 in Kenya and highlights the need for sustained genomic surveillance in Kenya and Africa to better understand how the virus evolves. Such surveillance ensures detection of drifts in evolution, allowing information for updates in vaccines, policy making, and containment of future variants of SARS-CoV-2.Keywords
All Related Versions
Funding Information
- Rockefeller Foundation
- Bundesministerium für Wirtschaftliche Zusammenarbeit und Entwicklung
- National Institute of Allergy and Infectious Diseases (R01AI168232)
- National Institute of Allergy and Infectious Diseases (U01AI151799)
This publication has 74 references indexed in Scilit:
- Key mutations in the spike protein of SARS‐CoV‐2 affecting neutralization resistance and viral internalizationJournal of Medical Virology, 2022
- Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen testsCell, 2022
- Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 OmicronCell, 2022
- A defective viral genome strategy elicits broad protective immunity against respiratory virusesCell, 2021
- Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistanceCell, 2021
- Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domainiScience, 2021
- Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 BindingCell, 2020
- Mutational spectra of SARS‐CoV‐2 orf1ab polyprotein and signature mutations in the United States of AmericaJournal of Medical Virology, 2020
- The Architecture of SARS-CoV-2 TranscriptomeCell, 2020
- Coronaviruses: An Overview of Their Replication and Pathogenesis2015